Norgine

About The Fund

Norgine is a leading European specialist pharmaceutical company with over a century of experience, founded in 1906 and headquartered in Amsterdam, Netherlands. They focus on developing, manufacturing, and marketing pharmaceutical products primarily within Western Europe. The company has a robust global network of partnerships enabling them to acquire, develop, and commercialize innovative products that significantly impact patient lives. Norgine prides itself on helping approximately 25 million patients worldwide annually. With an agile and adaptable infrastructure, Norgine partners in various ways, including licensing, acquisition, and special purpose vehicle (SPV) arrangements. They report over 500 million in net product sales, funded by their sustained growth that permits them to reinvest in innovating medicines for future needs. Norgine operates in multiple specialist therapy areas, such as gastroenterology and hepatology. The company emphasizes a unified 'One Norgine' approach, leveraging infrastructure optimized for performance and growth. Their team comprises over 1,400 dedicated employees who collectively contribute to the organization's ongoing success. Norgine's specialties include Acquisition and field expertise spanning from Software, Media, BioTech, Business Solutions, Hardware, Manufacturing, to HealthTech and Fitness. They are committed to expanding their core business and demonstrate a consistent pursuit of innovation and enhancement of patient healthcare. Additionally, Norgine is engaged in various responsible practices, ensuring compliance, transparency, and commitment to improving patient lives through the provision of unlicensed medicines. They also maintain a strong presence in corporate media and industry events to foster networking and partnership opportunities. The company has outlined detailed policies on invoicing, supplier conduct, privacy, information security, and legal stipulations, ensuring that ethics and professionalism are at the forefront of their business operations.